NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,590,665 | +50.0% | 447,582 | +48.6% | 0.06% | +52.5% |
| Q2 2023 | $30,399,662 | +15.3% | 301,255 | +5.1% | 0.04% | +5.3% |
| Q1 2023 | $26,359,181 | +0.5% | 286,513 | -0.9% | 0.04% | -2.6% |
| Q4 2022 | $26,230,376 | +14.6% | 289,136 | -4.0% | 0.04% | -2.5% |
| Q3 2022 | $22,890,000 | -13.4% | 301,150 | -3.7% | 0.04% | -9.1% |
| Q2 2022 | $26,441,000 | -12.0% | 312,804 | -8.7% | 0.04% | -6.4% |
| Q1 2022 | $30,051,000 | +298.2% | 342,466 | +296.9% | 0.05% | +291.7% |
| Q4 2021 | $7,547,000 | -12.2% | 86,281 | -17.9% | 0.01% | -20.0% |
| Q3 2021 | $8,597,000 | +30.7% | 105,127 | +45.8% | 0.02% | +25.0% |
| Q2 2021 | $6,578,000 | -10.8% | 72,103 | -16.4% | 0.01% | -20.0% |
| Q1 2021 | $7,372,000 | -12.7% | 86,243 | -3.5% | 0.02% | -21.1% |
| Q4 2020 | $8,443,000 | +12.3% | 89,413 | +3.0% | 0.02% | -5.0% |
| Q3 2020 | $7,519,000 | +14.8% | 86,798 | +15.8% | 0.02% | +5.3% |
| Q2 2020 | $6,548,000 | -11.6% | 74,970 | -16.5% | 0.02% | -26.9% |
| Q1 2020 | $7,404,000 | +1.0% | 89,797 | +16.0% | 0.03% | +18.2% |
| Q4 2019 | $7,328,000 | +14.0% | 77,393 | +4.6% | 0.02% | +4.8% |
| Q3 2019 | $6,430,000 | -4.4% | 73,993 | +0.4% | 0.02% | -8.7% |
| Q2 2019 | $6,726,000 | +0.0% | 73,665 | +5.3% | 0.02% | -4.2% |
| Q1 2019 | $6,724,000 | +7.7% | 69,943 | -3.9% | 0.02% | -7.7% |
| Q4 2018 | $6,245,000 | +2.7% | 72,772 | +3.2% | 0.03% | +13.0% |
| Q3 2018 | $6,078,000 | +39.1% | 70,546 | +21.9% | 0.02% | +35.3% |
| Q2 2018 | $4,371,000 | -5.9% | 57,868 | +0.7% | 0.02% | -10.5% |
| Q1 2018 | $4,646,000 | -7.4% | 57,465 | -3.9% | 0.02% | -13.6% |
| Q4 2017 | $5,019,000 | -0.7% | 59,777 | +1.5% | 0.02% | -4.3% |
| Q3 2017 | $5,056,000 | +10.1% | 58,890 | +7.0% | 0.02% | 0.0% |
| Q2 2017 | $4,592,000 | +6.3% | 55,017 | -5.4% | 0.02% | -4.2% |
| Q1 2017 | $4,320,000 | -9.0% | 58,165 | -10.8% | 0.02% | -17.2% |
| Q4 2016 | $4,749,000 | -6.1% | 65,199 | +1.8% | 0.03% | -9.4% |
| Q3 2016 | $5,059,000 | +115.0% | 64,067 | +124.6% | 0.03% | +88.2% |
| Q2 2016 | $2,353,000 | +10.0% | 28,520 | -3.4% | 0.02% | 0.0% |
| Q1 2016 | $2,139,000 | -11.2% | 29,522 | +5.4% | 0.02% | -15.0% |
| Q4 2015 | $2,410,000 | -26.7% | 28,010 | -21.7% | 0.02% | -31.0% |
| Q3 2015 | $3,288,000 | +15.8% | 35,762 | +23.9% | 0.03% | +11.5% |
| Q2 2015 | $2,839,000 | +17.2% | 28,872 | +17.5% | 0.03% | +13.0% |
| Q1 2015 | $2,422,000 | +10.2% | 24,562 | +3.6% | 0.02% | 0.0% |
| Q4 2014 | $2,197,000 | -12.1% | 23,711 | -10.7% | 0.02% | -20.7% |
| Q3 2014 | $2,499,000 | +43.4% | 26,546 | +37.9% | 0.03% | +26.1% |
| Q2 2014 | $1,743,000 | +18.0% | 19,249 | +10.8% | 0.02% | +4.5% |
| Q1 2014 | $1,477,000 | +17.4% | 17,373 | +11.0% | 0.02% | +4.8% |
| Q4 2013 | $1,258,000 | -1.8% | 15,646 | -6.3% | 0.02% | -16.0% |
| Q3 2013 | $1,281,000 | +73.3% | 16,699 | +59.7% | 0.02% | +47.1% |
| Q2 2013 | $739,000 | – | 10,457 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |